Early Mortality Risk Score: Identification of Poor Outcomes Following Upfront Surgery for Resectable Pancreatic Cancer
- 7 February 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Gastrointestinal Surgery
- Vol. 16 (4), 753-761
- https://doi.org/10.1007/s11605-011-1811-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Resectable Pancreatic Cancer: Who Really Benefits From Resection?Annals of Surgical Oncology, 2009
- Diagnostic Value of EUS-FNA in Patients Suspected of Having Pancreatic Cancer With a Focal Lesion on CT Scan/MRI but Without Obstructive JaundicePancreas, 2009
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2009
- Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins HospitalJournal of Clinical Oncology, 2008
- Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of DiseaseJournal of the American College of Surgeons, 2008
- On Statistical Reanalysis, the EORTC Trial Is a Positive Trial for Adjuvant Chemoradiation in Pancreatic CancerAnnals of Surgery, 2006
- One Thousand Consecutive PancreaticoduodenectomiesAnnals of Surgery, 2006
- Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival DurationAnnals of Surgical Oncology, 2001
- Survival Analysis Techniques for Censored and Truncated DataTechnometrics, 1998